Antihypertensive drug combination

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/00 (2006.01) A61K 31/165 (2006.01) A61K 31/505 (2006.01) A61P 9/12 (2006.01)

Patent

CA 2677822

Therapeutic combinations and pharmaceutical compositions are provided comprising darusentan and an inhibitor of renin activity or release in absolute and relative amounts effective to provide a beneficial change in a subject's 24-hour pattern of systolic and/or diastolic blood pressure. There are further provided methods of using such combinations or compositions to treat hypertensive disorders, or to lower blood pressure in subjects exhibiting resistance to a baseline antihypertensive therapy.

L'invention concerne des combinaisons thérapeutiques et des compositions pharmaceutiques comprenant du darusentan et un inhibiteur d'activité ou de libération de rénine en des quantités absolues et relatives efficaces pour apporter un changement salutaire dans le modèle de pression artérielle systolique et/ou diastolique d'un patient sur une durée de 24 heures. L'invention concerne en outre des procédés d'utilisation de telles combinaisons ou compositions pour traiter des troubles de l'hypertension, ou pour diminuer la pression artérielle chez des sujets présentant une résistance à un traitement antihypertenseur de base.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Antihypertensive drug combination does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antihypertensive drug combination, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antihypertensive drug combination will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2067698

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.